- Home
- USEA vs SSKN Comparison
USEA vs SSKN Comparison
Compare USEA & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- SSKN
- Stock Information
- Founded
- USEA 2004
- SSKN 1989
- Country
- USEA Greece
- SSKN United States
- Employees
- USEA N/A
- SSKN N/A
- Industry
- USEA Marine Transportation
- SSKN Medical/Dental Instruments
- Sector
- USEA Consumer Discretionary
- SSKN Health Care
- Exchange
- USEA Nasdaq
- SSKN Nasdaq
- Market Cap
- USEA 10.5M
- SSKN 9.7M
- IPO Year
- USEA N/A
- SSKN 2005
- Fundamental
- Price
- USEA $1.44
- SSKN $2.31
- Analyst Decision
- USEA Strong Buy
- SSKN Strong Buy
- Analyst Count
- USEA 1
- SSKN 1
- Target Price
- USEA $6.00
- SSKN $6.00
- AVG Volume (30 Days)
- USEA 193.4K
- SSKN 10.4K
- Earning Date
- USEA 08-05-2025
- SSKN 08-13-2025
- Dividend Yield
- USEA 2.74%
- SSKN N/A
- EPS Growth
- USEA N/A
- SSKN N/A
- EPS
- USEA N/A
- SSKN N/A
- Revenue
- USEA $42,595,000.00
- SSKN $33,620,000.00
- Revenue This Year
- USEA N/A
- SSKN $3.31
- Revenue Next Year
- USEA $11.62
- SSKN $9.67
- P/E Ratio
- USEA N/A
- SSKN N/A
- Revenue Growth
- USEA N/A
- SSKN 3.30
- 52 Week Low
- USEA $1.00
- SSKN $2.10
- 52 Week High
- USEA $2.78
- SSKN $3.80
- Technical
- Relative Strength Index (RSI)
- USEA 54.19
- SSKN 44.33
- Support Level
- USEA $1.31
- SSKN $2.33
- Resistance Level
- USEA $2.00
- SSKN $2.40
- Average True Range (ATR)
- USEA 0.11
- SSKN 0.09
- MACD
- USEA 0.02
- SSKN -0.00
- Stochastic Oscillator
- USEA 27.27
- SSKN 30.56
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.